Health ❯Healthcare ❯Pharmaceuticals ❯Drug Regulation

FDA Decisions

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

The resolution of the Ozempic and Wegovy shortage prompts regulatory deadlines for compounding pharmacies to cease production of cheaper alternatives.

11 ARTICLES

8mo ago

FDA Rejects MDMA for PTSD Treatment, Requests More Trials

FDA Decisions

FDA Declares Semaglutide Shortage Over, Impacting Compounded Drug Market

FDA Ends Shortage of Eli Lilly’s Weight-Loss Drug, Restricts Copycat Versions

FDA Moves to Ban Ineffective Oral Phenylephrine from Cold Medicines

FDA Reconsiders Ban on Compounded Versions of Eli Lilly's Weight Loss Drug

FDA Rejects MDMA for PTSD Treatment, Requests More Trials